The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Authors

Tammie L.S. Benzinger, Washington University School of Medicine in St. Louis
Celeste M. Karch, Washington University School of Medicine in St. Louis
Anne Fagan, Washington University School of Medicine in St. Louis
John C. Morris, Washington University School of Medicine in St. Louis
Randall J. Bateman, Washington University School of Medicine in St. Louis
et al

Journal

Acta Neuropathologica Communications

Publication Date

2018

Volume

6

Inclusive Pages

130

Document Type

Open Access Publication

DOI

10.1186/s40478-018-0624-z

Rights and Permissions

Twohig et al. Acta Neuropathologica Communications (2018) 6:130 https://doi.org/10.1186/s40478-018-0624-z © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Recommended Citation

Benzinger, Tammie L.S.; Karch, Celeste M.; Fagan, Anne; Morris, John C.; Bateman, Randall J.; and et al, "The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease." Acta Neuropathologica Communications. 6, 130. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7524